Carroll Investors, Inc Albemarle Corp Transaction History

Carroll Investors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$162.63 - $243.44 $414,381 - $620,285	-2,548 Reduced 38.95%	3,993 $678,000
Q2 2023 Aug 09, 2023	BUY	$172.91 - $232.22 $19,365 - $26,008	112 Added 1.74%	6,541 $1.46 Million
Q1 2023 May 15, 2023	BUY	$208.49 - $290.15 $189,725 - $264,036	910 Added 16.49%	6,429 $1.42 Million
Q4 2022 Feb 14, 2023	BUY	$214.02 - $325.38 $825,475 - $1.25 Million	3,857 Added 232.07%	5,519 $1.2 Million
Q3 2022 Nov 14, 2022	BUY	$195.82 - $307.05 $325,452 - $510,317	1,662 New	1,662 $441,000

922

105M

8.55M

14.7M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $8.97B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Carroll Investors, Inc, based on Form 13F filings with the SEC.

Stay updated on Carroll Investors, Inc with notifications on news.